Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
4,708,425
-
Share change
-
+2,965,813
-
Total reported value
-
$5,228,000
-
Price per share
-
$1.11
-
Number of holders
-
14
-
Value change
-
+$3,270,988
-
Number of buys
-
7
-
Number of sells
-
3
Institutional Holders of VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) as of Q4 2017
As of 31 Dec 2017,
VISTAGEN THERAPEUTICS INC - COM NEW (VTGN) was held by
14 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,708,425 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, SPHERA FUNDS MANAGEMENT LTD., SUSQUEHANNA INTERNATIONAL GROUP, LLP, NEXTHERA CAPITAL LP, LADENBURG THALMANN FINANCIAL SERVICES INC., D.A. DAVIDSON & CO., ALPINE WOODS CAPITAL INVESTORS, LLC, Parallax Volatility Advisers, L.P., GEODE CAPITAL MANAGEMENT, LLC, and HighTower Advisors, LLC.
This page lists
14
institutional shareholders reporting positions in this security
for the Q4 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.